IP Verse

Intermune competitive analysis

Loading summary...

Latest patents of Intermune opposed by its competitors

Explore Intermune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3053580
Jun 30, 2021Method Of Providing Pirfenidone Therapy To A Patient4
EP2653162
May 20, 2020Methods Of Administering Fluvoxamine Therapy4
EP2506850
May 13, 2020Methods Of Administering Pirfenidone Therapy6

Latest publications and patents of Intermune New

Explore the latest publications and patents granted to Intermune, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Intermune

EP3053580
Jun 30, 2021Method Of Providing Pirfenidone Therapy To A PatientGranted And Under Opposition
EP2653162
May 20, 2020Methods Of Administering Fluvoxamine TherapyRevoked
EP2506850
May 13, 2020Methods Of Administering Pirfenidone TherapyRevoked

Latest PTAB cases involving Intermune

Discover the latest PTAB cases involving Intermune, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Intermune with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERMUNE - 14 - -
AERA27 - - -
ALFRED E TIEFENBACHER443 - -
GENERICS UK214 - - -